Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease

Abroad (travel likely)Recruiting

Conditions

Chronic Obstructive Pulmonary Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cardinal Tien Hospital, New Taipei City, Taiwan
Contact: Study coordinator (Ke-Yun Chao, PhD) · ck_qq@hotmail.con · +886-905-301-879
Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan
Contact: Study coordinator (Ke-Yun Chao, PhD) · ck_qq@hotmail.con · +886-905-301-879

Study leads

Ke-Yun Chao, PhD
Principal Investigator
Fu Jen Catholic University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment Response

Asthma (Diagnosis) · COPD (Chronic Obstructive Pulmonary Disease)

Abroad (travel likely)Recruiting

Seoul, South Korea · Seoul, South Korea

This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Chronic Obstructive Pulmonary Disease

Abroad (travel likely)Recruiting

Anhui, China · Anning, China

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

Chronic Obstructive Pulmonary Disease COPD

Abroad (travel likely)Recruiting

Aix-en-Provence, France · Blois, France

Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

Chronic Obstructive Pulmonary Disease

Abroad (travel likely)RecruitingPHASE4

Marburg, Germany · Groningen, Netherlands